EBS
#3170
Emergent BioSolutions Inc. Common Stock
6.7 8 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.42%
Monthly Change
+39.22%
6 month change
-16.30%
Year Change
-36.75%
Previous Close
7.0 2
Open
6.8 5
Low
6.7 7
High
6.8 7
Volume
472
Financials
- Market Capitalization 347.63 M
- Employee 900
- Founded 1998
- CEO Robert G. Kramer Sr. | Joseph C. Papa
- Website www.emergentbiosolutions.com
- Headquarter Delaware, United States
- FIGI BBG000GW06J7
- Industry Drug Manufacturers—Specialty & Generic
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
13.29
Price to sales ratio
0.94
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3054 |  CGC Canopy Growth Corporation - Common Shares | 0.93 USD | -1.06% | 0.00% | -11.43% | -31.11% | 393.43 M USD | ||
| 3104 |  BIOA BioAge Labs, Inc. - Common Stock | 8.06 USD | -0.37% | -5.62% | -24.25% | +6.05% | 369.93 M USD | ||
| 3348 |  ANIK Anika Therapeutics Inc. - Common Stock | 20.81 USD | -1.05% | -0.24% | -1.61% | +105.23% | 278.50 M USD | ||
| 3419 |  AKBA Akebia Therapeutics, Inc. - Common Stock | 0.92 USD | +2.22% | -3.16% | +4.55% | -22.03% | 254.94 M USD |
Frequently asked questions about Emergent Biosolutions, Inc.
What is the Emergent Biosolutions, Inc. stock price today?
The current price of Emergent Biosolutions, Inc. (EBS) is 6.78. Over the past 24 hours, the stock has changed by -3.42%. Follow the EBS chart for real-time price dynamics.
What is the stock ticker of Emergent Biosolutions, Inc.?
Emergent Biosolutions, Inc. trades under the ticker EBS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Emergent Biosolutions, Inc. stock going up?
EBS has changed by +9.00% over the last week, +39.22% over the last month, and -36.75% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Emergent Biosolutions, Inc.?
Emergent Biosolutions, Inc. currently has a market capitalization of 347.63 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Emergent Biosolutions, Inc. earnings last quarter?
Last quarter, Emergent Biosolutions, Inc. reported earnings of -3.49 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Emergent Biosolutions, Inc. revenue for the last quarter?
Emergent Biosolutions, Inc. reported quarterly revenue of 234.3 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Emergent Biosolutions, Inc. net income for the last quarter?
Emergent Biosolutions, Inc. reported net income of -180.2 M for the last quarter. The previous quarter showed 6.8 M, which means net income changed by -2750.00%.
How many employees does Emergent Biosolutions, Inc. have?
As of the latest available data, Emergent Biosolutions, Inc. has 900 employees. Workforce size can provide additional context about the company's scale and operations.
What is Emergent Biosolutions, Inc. EBITDA?
Emergent Biosolutions, Inc. EBITDA is -244 M, and its EBITDA margin is -104.14%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Emergent Biosolutions, Inc. stock?
You can buy Emergent Biosolutions, Inc. (EBS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Emergent Biosolutions, Inc. stock?
Investing in Emergent Biosolutions, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the EBS chart and related analysis on metatrader.com as part of your research.